PATENT CLAIM ANALYSIS

Application Number: 16270837
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "494000"]

Abstract:
The present invention provides a simple and improved dose form that is capable of providing a controlled release of GABA B  receptor agonist contained in the core thereof. The invention also provides methods of administering the dosage form and of treating conditions that are therapeutically responsive to GABA B  receptor agonist.

Claim (Index 2):
The method of  claim 1 , wherein the condition, disorder or disease is selected from the group consisting of spasticity, spastic diplegia, spasticity associated with multiple sclerosis, amyotrophic lateral sclerosis, trigeminal and glossopharyngeal neuralgias, spinal cord injury, alcoholism, alcohol addiction, dependence or alcohol abuse, gastro-esophageal reflux disease, emesis, cough, narcotic addiction or abuse, nicotine addiction or abuse, neuropathic pain and musculoskeletal pain, nocturnal acid breakthrough, chronic hiccups, dyspepsia, non-nuclear dyspepsia, gastric motility disorder, migraine, Post-traumatic Stress Disorder, depression, anxiety, and lower urinary tract dysfunction.

Metadata:
- Claim Count in Document: 113.0
- Percentile: 99.0
- Lexical Diversity: 1.43243
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15146525', '15919422', '15048743', '15919436', '15132972']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8747640877004109
- 35 USC 102 Novelty (BERT): 0.6572030879681691
- Combined Prediction Score: 0.8530079877271868
- Mean Citation Score: 576.303538
- Max Citation Score: 585.8544
- Similarity Product: 576.6201447398187

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test